Recent News

• 03.02.2026 - Tectonic Therapeutic to Participate in March Investor Conferences
• 02.26.2026 - Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
• 02.23.2026 - Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
• 02.11.2026 - Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026

Recent Filings

• 02.27.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2026 - 8-K Current report
• 02.26.2026 - EX-99.1 EX-99.1
• 02.24.2026 - EX-99.1 EX-99.1
• 02.24.2026 - 8-K Current report
• 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.11.2026 - 4 Statement of changes in beneficial ownership of securities